Literature DB >> 12270082

Interpreting changes in heroin supply in Melbourne: droughts, gluts or cycles?

Paul Dietze1, John Fitzgerald.   

Abstract

In this Harm Reduction Digest Paul Dietze and John Fitzgerald provide another possible way of understanding what has come to be referred to as Australia's heroin 'drought'. They examine evidence from Melbourne, Victoria and suggest that the apparent downturn in heroin availability in 2000 may, in part, be the result of an end of a heroin 'glut' and that perceptions of this phenomenon may be coloured by the development of more sophisticated indicators of the heroin market. They conclude with claims that the reasons for the reduction in drug consumption and adverse health outcomes, such as those attributed to interdiction, are thus premature

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270082     DOI: 10.1080/0959523021000002778

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  10 in total

1.  Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study.

Authors:  Jenny Iversen; Handan Wand; Libby Topp; John Kaldor; Lisa Maher
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

2.  'It's more about the heroin': injection drug users' response to an overdose warning campaign in a Canadian setting.

Authors:  Thomas Kerr; Will Small; Elaine Hyshka; Lisa Maher; Kate Shannon
Journal:  Addiction       Date:  2013-03-28       Impact factor: 6.526

3.  Heroin in brown, black and white: structural factors and medical consequences in the US heroin market.

Authors:  Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2008-10-21

4.  Drug use among homeless young people in Los Angeles and Melbourne.

Authors:  Doreen Rosenthal; Shelley Mallett; Norweeta Milburn; Mary Jane Rotheram-Borus
Journal:  J Adolesc Health       Date:  2008-09       Impact factor: 5.012

5.  Dynamic compartmental model of trends in Australian drug use.

Authors:  Jonathan P Caulkins; Paul Dietze; Alison Ritter
Journal:  Health Care Manag Sci       Date:  2007-06

6.  The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.

Authors:  C K Aitken; P A Agius; P G Higgs; M A Stoové; D S Bowden; P M Dietze
Journal:  Epidemiol Infect       Date:  2016-12-08       Impact factor: 4.434

7.  Identification and quantification of change in Australian illicit drug markets.

Authors:  Stuart Gilmour; Inge Koch; Louisa Degenhardt; Carolyn Day
Journal:  BMC Public Health       Date:  2006-08-03       Impact factor: 3.295

8.  The "lessons" of the Australian "heroin shortage".

Authors:  Louisa Degenhardt; Carolyn Day; Stuart Gilmour; Wayne Hall
Journal:  Subst Abuse Treat Prev Policy       Date:  2006-05-02

9.  Illicit drug use and harms in Australia in the context of COVID-19 and associated restrictions: Anticipated consequences and initial responses.

Authors:  Paul M Dietze; Amy Peacock
Journal:  Drug Alcohol Rev       Date:  2020-05

10.  Establishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up results.

Authors:  Danielle Horyniak; Peter Higgs; Rebecca Jenkinson; Louisa Degenhardt; Mark Stoové; Thomas Kerr; Matthew Hickman; Campbell Aitken; Paul Dietze
Journal:  Harm Reduct J       Date:  2013-06-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.